Pediatric-Specific Bundle Offers New Strategy to Prevent Ventilator-Associated Pneumonia in Children
VAP, the second most common hospital-associated infection in pediatric intensive care units, is linked to increased morbidity, mortality and lengths of stay in the hospital and intensive care unit, adding tremendously to healthcare costs. Prevention is the most appropriate intervention, but no official guidelines have been published for VAP prevention in infants and children, and little research has been done in children to guide bedside care.
The article, titled "Preventing Ventilator-Associated Pneumonia in Children: An Evidence-Based Protocol," assembles evidence-based practice recommendations and integrates pediatric-specific interventions with a proven adult model to propose new strategies bedside nurses can implement to prevent this important healthcare problem.
The bundled prevention protocol for support of infants and children receiving mechanical ventilation focuses on suctioning or airway clearance, ventilator circuit changes and oral care.
Researchers Virginia Cooper, RN, MS, and Catherine Haut, DNP, CPNP/AC, CCRN, developed the recommendations. Cooper practices as a nurse in the pediatric intensive and intermediate care units at the University of Maryland Medical Center, Baltimore. Haut is the program director of the acute care pediatric nurse practitioner program at the University of Maryland School of Nursing and practices as a pediatric nurse practitioner in the pediatric intensive care unit at Herman & Walter Samuelson Children's Hospital at Sinai, Baltimore.
"Critical care nurses play an important role in identification of risk factors and prevention of ventilator-associated pneumonia," Cooper said. "The care bundle we propose offers evidence-based alerts and consistent prevention strategies for providers caring for children in the pediatric intensive care unit."
The researchers also call for additional research to document the effectiveness of bedside protocols to prevent VAP in infants and children. Maintaining data collection over time with the use of the VAP bundle will supply critical information on the effectiveness of these nursing and respiratory interventions in changing the incidence of VAP in a particular setting.
Access the article abstract and full-text PDF by visiting the CCN website at www.ccnonline.org.
Source: American Association of Critical-Care Nurses via PR Newswire
Published on : Thu, 6 Jun 2013
The iLA Membrane Ventilator is an extrapulmonary ventilation system which is used primarily to remove carbon dioxide. The heart pumps blood through it as it does through a natural organ. The gas exchange takes place via a plasma-tight, heparin-coated...
The fully featured ICU ventilator, HAMILTON-MR1, guarantees uncompromised continuous ventilation care from the ICU to the MRI scanner and back. Its reliability and high performance, with advanced lung-protective strategies and patient-adaptive modes,...
Features The SynoVent E3 does not only include advanced ventilator functionality but also a modern, easy to use interface. The display can be configured to suit each clinician’s taste and needs, and gives quick and easy control over ventilator...
XENIOS AG is a medical device company with the three brands, novalung, i-cor and medos, that run on a single XENIOS platform. This platform enables next-generation therapies for lung and heart failure. No other company except XENIOS AG is offering lung...